Compare Johnson & Johnson (JNJ) vs Rent the Runway Inc (RENT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Rent the Runway Inc — how do they compare? Johnson & Johnson trades at $261.41 (market cap $618.09B), while Rent the Runway Inc trades at $1.76 (market cap $61.75M). The key difference: Johnson & Johnson is far larger — about 10009.6× Rent the Runway Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while Rent the Runway Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Rent the Runway Inc for 56 Days on average.
| JNJ | RENT | |
|---|---|---|
Market Cap | $618.09B | $61.75M |
Volume | 6,050,983 | 193,323 |
Sector | Health | Consumer Cyclical |
52-Week High | $278.43 | $9.39 |
52-Week Low | $186.00 | $1.55 |
Typical Hold Time | 129 Days | 56 Days |
Enterprise Value | $646.37B | $228.75M |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
Rent the Runway (RENT) trades at $1.77, up 5.36% today, with a bullish technical signal despite mixed indicators. The company reported Q2 2026 revenue growth of 20.8% year-over-year to $97.7 million, with improved gross margins, and appointed Paige Thomas as CEO in September 2026. However, it faces negative shareholder equity of -$182.5 million and a high debt-to-asset ratio of 139.62% as of 2025, though net losses have narrowed from -$212 million in 2022 to -$69.9 million in 2025.
The outlook is cautiously optimistic, with revenue growth and margin expansion offering potential upside, but significant financial leverage and ongoing legal investigations pose substantial risks. Analyst consensus is mixed, with 42% buy ratings, reflecting the balance between operational improvements and balance sheet concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Rent the Runway Inc
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →
